Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2026 -151.03M
June 30, 2026 -193.82M
March 31, 2026 -172.93M
December 31, 2025 -156.75M
Date Value
September 30, 2025 -129.49M
June 30, 2025 -97.71M
March 31, 2025 -74.22M
December 31, 2024 -55.08M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Korsana Biosciences, Inc. -51.31M
IRulya Therapeutics, Inc. -46.91M
PepGen Inc. -63.28M
Q32 Bio, Inc. -20.07M
Oncolytics Biotech, Inc. -28.39M